Diphen and Samsca drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Diphen (diphenhydramine hydrochloride) and Samsca (tolvaptan). Common drug interactions include anaemia among females and bronchial carcinoma among males.

The phase IV clinical study analyzes what interactions people have when they take Diphen and Samsca. It is created by eHealthMe based on reports of 7 people who take the same drugs from the FDA, and is updated regularly.

What is Diphen?

Diphen has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 115,429 Diphen users. Check the latest studies of Diphen.

What is Samsca?

Samsca has active ingredients of tolvaptan. eHealthMe is studying from 8,139 Samsca users. Check the latest studies of Samsca.



On Dec, 29, 2025

7 people who take Diphen and Samsca together, and have interactions are studied.

Diphen and Samsca drug interactions.

What are the common drug interactions of Diphen and Samsca, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Abdominal distension
  3. Biliary tract disorder
  4. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  5. Burning sensation
  6. Eye irritation
  7. Ocular hyperaemia (an abnormally large amount of blood in eye)
  8. Rhinalgia (pain in the nose)
  9. Swelling
  10. Activities of daily living impaired

male:

  1. Bronchial carcinoma (lung cancer)
  2. Fatigue (feeling of tiredness)
  3. Neoplasm progression (growth of tumour)
  4. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  5. Respiratory tract infection
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Upper respiratory tract infection

What are the common drug interactions of Diphen and Samsca, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Activities of daily living impaired
  2. Altered state of consciousness (altered state of mind)
  3. Anaemia (lack of blood)
  4. C-reactive protein increased
  5. Clavicle fracture
  6. Constipation
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Disuse syndrome (deterioration of body systems as a result of prescribed or unavoidable inactivity)
  9. Dry skin
  10. Fall

30-39:

n/a

40-49:

  1. Anaemia (lack of blood)
  2. Burning sensation
  3. Eye irritation
  4. Ocular hyperaemia (an abnormally large amount of blood in eye)
  5. Rhinalgia (pain in the nose)
  6. Swelling

50-59:

n/a

60+:

  1. Glomerular filtration rate decreased
  2. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  3. Melaena (the passage of black, tarry stools)
  4. Neoplasm progression (growth of tumour)
  5. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  6. Respiratory tract infection
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Upper respiratory tract infection
  9. Pruritus (severe itching of the skin)
  10. Abdominal distension

* Approximation only. Some reports may have incomplete information.

Do you take Diphen and Samsca?

- Personalize this study to your gender, age, symptoms and drugs (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Diphen and Samsca:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Diphen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Samsca:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diphen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Samsca and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diphenhydramine hydrochloride and tolvaptan (the active ingredients of Diphen and Samsca, respectively), and Diphen and Samsca (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: